Dr. Della Sheryl Roberts-mckay, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 205 Route 59 Ste 4, Spring Valley, NY 10977 Phone: 845-371-6640 |
Dr. Michael J Berman, OD Optometrist Medicare: Medicare Enrolled Practice Location: 10 Spring Valley Market Pl, Spring Valley, NY 10977 Phone: 845-426-3937 Fax: 845-426-3937 |
Dr. Robert Neal Becker, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10 Spring Valley Market Pl, Spring Valley, NY 10977 Phone: 845-426-3937 Fax: 845-426-3937 |
Aniko Boros, MSED.,TVI Optometrist - Vision Therapy Medicare: Not Enrolled in Medicare Practice Location: 8 Christa Lynn Dr, Spring Valley, NY 10977 Phone: 845-290-6910 |
News Archive
California Gov. Arnold Schwarzenegger (R) on Friday signed five bills into law that allow California to receive more than $17.5 billion in federal economic stimulus aid, but the funding will not be enough for the state to avoid $3 billion in tax increases and cuts to services to balance its budget, the San Francisco Chronicle reports.
ViroPharma, Inc. today announced that, in connection with the completion of the acquisition of ViroPharma by Shire plc (LSE: SHP, NASDAQ: SHPG), it has commenced a tender offer (the "Convertible Notes Tender Offer") to repurchase, at the option of each holder, any and all of its outstanding 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes").
The impact that cancer has on society cannot be underestimated. Throughout our lives one in two of us will be diagnosed with a form of cancer, with the disease accounting for an estimated 9.6 million deaths worldwide in 2018.
Today it was announced that Women & Infants Hospital of Rhode Island, a Care New England Hospital, has received the 2015 Women's Choice Award as one of America's Best Hospitals for Obstetrics. This evidence-based designation identifies the country's best health care institutions based on robust criteria that consider female patient satisfaction, clinical excellence and what women say they want from a hospital.
Convergent Dental, Inc., a privately held dental device and technology company, announced today that the U.S. Food and Drug Administration (FDA) has cleared Soleaâ„¢ for ablation of hard tissue for caries removal and cavity preparation. Solea is the first CO2 laser technology system that has received FDA clearance for hard tissue indications.
› Verified 7 days ago